Is Pfizer Stock Really Soaring on Vaccine News?
As so many are reveling in the apparent success of Pfizer’s vaccine trials, we might think that their stock should be going crazy. Lots of craziness, none related to the stock.
The headline from Bloomberg when the news of Pfizer’s COVID vaccine achieving a 90% efficacy rate claimed that Pfizer’s stock was “soaring,” and many might think that news like this should send a stock through the roof, which instantly placed the company’s vaccine into first place.
People who may have bought the stock a few months ago might think that their ship has come in with news like this, but like pretty much everything related to this virus, the myth is much bigger than the reality.
For those who choose to invest in stocks like this, hoping for a big payday, it’s pretty important to seek to understand what is really going on and not just rely on press releases by the companies or horn tooting by pubic officials. The actors on stage may be playing their roles well, but we really need to know what’s happening backstage if we want a true sense of what we are getting into with betting on this stuff.
There is always two sides to a story, and this vaccine one is no different, and in fact the difference between what the shills tell you and what experts who are free from this obvious bias and are not just looking to spin the thing is a pretty large one as it turns out.
Pfizer has upped its efficacy rate to 95% now to keep up with Moderna who jockeyed back in forth by finding bigger and bigger numbers much like an auction. What do these numbers even mean though?
This might seem that all we need to do is all take one of these vaccines and we’ll have this alleged pandemic beat. We’re even told that it is safe, and we don’t ask many questions these days, especially with things that have such an appearance of good news like many people see these results as promising. We’ve been told that a vaccine will “save” us, the savior is now on the way, this pandemic is so dreadful, isn’t this all fantastically wonderful?
If we can manage to step outside this party and have a real look at what we are celebrating, we might see that there is not such a need to celebrate, and we might even become concerned about the prospects of such a vaccine being rolled out, perhaps very concerned.
We need to start with the perspective of what we are really dealing with, to go beyond the official story and see what the extent of this problem really is. Surely this cannot be the number of deaths recorded as COVID deaths, even if we insist on counting all of the deaths where the patient has clearly died of something else, and given that the CDC has instructed doctors to use COVID as the cause and count it among its alleged deaths even if patients die of an unrelated condition.
The threshold that the CDC has set is if COVID is even seen as a contributing factor, the patient will be deemed to have died of COVID, which is not how we normally assign causes of death. Assigning this as a contributing factor is a nebulous task as it turns out, and what we have been doing is attributing all deaths where the patient has been found to “have” COVID to COVID.
COVID, like other respiratory infections, kills people in specific ways that are pretty easy to determine. The body’s immune system unleashes a massive attack on not just the virus but the body itself, specifically the lungs. Heart attacks, cancer, and all the other causes of death that have been mistakenly categorized as COVID deaths also kill us in specific ways obvious to a pathologist in the great number of cases.
It has been estimated that out of every 100 official COVID deaths, only 6 actually die of COVID, with the other 94 dying of something else. This has created a bizarre outcome where official death counts from diseases like cancer have gone down notably, not because less people are dying from it, but from so many of these cancer deaths and deaths from other causes not related to respiratory infection being repurposed to pump up the COVID numbers.
To make sure this all goes as planned, the government, as part of the COVID aid package, is paying hospitals a lot more money if the death was due to COVID. This is not misconduct at the practitioner level though, they are just doing what the CDC is telling them to do and pocketing the extra money as a bonus.
Creating a Market of Fear
As it turns out, the threshold for determining whether COVID caused a death is a positive PCR test. Even Tony Fauci understands how brutally inaccurate these tests are, and at a virology conference in July, he told us how worthless it is to have these tests done with a cycle rate over 35. We use a cycle rate of 37 to 40 and Fauci was seen wringing his hands over this because he told us that this just has us detecting dead viral remnants that have no possibility of infection or transmission.
So you die of a heart attack or cancer or something completely unrelated to a viral infection, they find dead remnants of this virus, and you somehow died of COVID. This test also allows them to misrepresent the number of infections out there, these “cases” that required us to redefine the term case because that used to require some sort of illness, but no more.
The real reason why there is such a high correlation with “co-morbidities” is that these co-morbidities are the actual morbidities. They are riding on the backs of these major killers and end up getting the credit. For the most part, it is these other conditions that kill you. Cancer and COVID together has a higher death rate than just COVID of course, since so many people die of cancer.
The real reason why we see 90% of COVID cases being “asymptomatic” is that 90% of these people are not infected by COVID at all. Dead viral proteins do not produce cases of any sort, as a viral infection is actually required to say that you have a viral infection. The level of misrepresentation that we have been subject to is appalling beyond belief.
Just for good measure, we have continued to increase the number of these completely unreliable tests that we run, where the positivity rate goes down but we do enough additional ones to create the illusion that these fake cases are spiking. This has people clamoring more and more for a vaccine, which may be the ultimate intent.
If we own Pfizer stock, this might even be something that may excite us, that they have drummed up this exaggerated pandemic and we’re now getting ready to profit from it. It is 90% effective, or 95% effective, and that sure does sound exciting. Effective at what though is the big question.
Dr. Peter Doshi of the British Medical Journal, among others, are stepping up to enlighten us a little more about what these vaccines are designed and not designed to do. Dr. Doshi is a professor of pharmacology at the University of Maryland and has been selected to an editor of this prestigious medical journal based upon his leading expertise in the field.
Dr. Doshi tells us that the public views vaccine efficacy as the ability of a vaccine to protect against viral spread as well as to reduce serious illness requiring hospitalization and death from an outbreak. These vaccines are not designed to help us with any of this as it turns out.
When a new treatment is rolled out, they start with Phase I trials, on animals. The phase 1 trials utterly failed in stopping transmission or providing any practical benefits at all, but theoretical benefits are enough for them, so they just set their sights much lower as a result of these failures and shot for showing “efficacy” that was apart from any real practical value.
In these Phase III trials that are being so loudly trumpeted, Dr. Doshi points out that these trials have given up on seeking outcomes such as reducing transmission, reducing hospitalization, and reducing the death rate and these outcomes are not even being tracked anymore, because they already know that there vaccines are not capable of such things and do not want to make this more transparent than it already is, although this has successfully been well kept away from the popular media that just about everyone gets all their information from these days.
Proclaiming Something Safe Does Not In Itself Make it So
Enhancing our immune response to COVID might seem like a good thing, a wonderful thing even, but this is not only trivial, it actually is pretty concerning. People die of COVID due to an overly accentuated immune response to it, where immunity goes crazy in a small percentage of patients and attacks our lungs in a deadly fashion. Otherwise, our immune systems handle this just fine, the ones that actually get the infection, where its symptoms are similar to a cold.
A properly functioning immune system relies on balance, a response strong enough to keep pathogens under control but not too strong to have it attack us as well. Too low and too high are both dangerous. Trying to achieve inoculation by way of injection is a dangerous practice in itself as it has been shown to promote autoimmunity and this is believed to be the reason why autoimmune diseases have escalated in lock step with the increase in vaccinations, especially among children who thus far have borne the brunt of this campaign.
We are just told that these vaccines are safe and expected to believe it without evidence. ICANN sued the CDC to have them ordered to produce evidence of their claims that vaccines are safe, and under court order, the best they could do is to produce studies that affirmed the fact that we do not have any evidence of safety and lots of evidence to the contrary.
Somehow, these new vaccines are also being deemed safe, much like King Arthur would dub a Knight with his sword, and if we are looking to invest in these companies, we can’t just take the King’s word for it. Vaccines can cause harm immediately, or it can take time, and sometimes years. There is just no way of knowing much at all about the safety of a trial so short and with so few subjects.
It may comfort us if we own Pfizer stock that Pfizer and other vaccine makers have complete legal immunity in the U.S., and are insisting on 4 years of it in countries where they do not have this protection. However, their refusing to offer vaccines in countries that do not indemnify them shows that we are not taking about no risk or anything but a big risk longer term.
Pharmaceutical companies do not enjoy this with their other products, and get sued often, and companies tolerate this without any issues. Vaccine companies refuse to offer their vaccines unless they can’t be sued for it. This is nothing like the risk from other treatments, it is on a whole different scale.
This is little solace to investors though, because while all the injuries from vaccines are kept from the public, COVID has changed everything with the maniacal focus that we have on it now. The few serious injuries that happened with these trials made national media, something normally far, far away from the public view.
Pharmaceutical stocks are among the riskiest out there, not so much because their prices move, as from the fact they can move a lot at various times from both good and bad news. It’s the bad news we’re worried about and this is where the risk of a big negative event could punish our stocks.
The idea that we could call a mRNA vaccine safe from just a brief trial is particularly ludicrous. We are told that what they inject will be gone from our bodies in 2 days, but something that changes your DNA can have long lasting effects, and you can even pass these things on for generations. We have never studied these things on humans. We’re about to study it, with a massive percentage of the population.
We are opening Pandora’s box, but the media is portraying this as safe, in the absence of even a mention of any risks. We simply do not know what will happen with this, but a big concern is that it will overstimulate our immune systems which is harmful and leads to the body attacking itself to produce various autoimmune diseases. They are exploding in children as we vaccinate them more and more, and adults are prone to these things too, especially the elderly.
If something does go badly wrong, we’re putting the elderly in the line of fire first, who are the ones most at risk. The biggest first hurdle is to see if these vaccines produce enhancement, which increases the excessive immune response that kills you with this virus to where you get affected by it 3 times worse. Up until now, we haven’t been able to come up with any coronavirus vaccine that avoids this dreadful problem, and we’re left to guess if these vaccines will or not.
There is a lot to worry about here and we want to worry about our stocks as investors as well. We’ve been preaching caution throughout this pandemic when it comes to these vaccine stocks, and this has to do with the way all this extra risk plays out in the risk to reward calculation that we must make.
It’s not like Pfizer stock is really going anywhere, and when you get news that hits the jackpot and your stock barely moves, the upside of this does not seem to be all that much. Together with the higher risk, this makes this an undesirable play from either side, long or short.
When your stock is only up 2% in the Year of the Coronavirus, and you are a pharmaceutical company with a leading vaccine that is getting ready to be rolled out soon, if the good times can’t move this stock, we need to wonder what would happen if the good times turn sour. Pfizer hasn’t soared like Bloomberg suggests, and it’s trading pretty much in the same range as it was before their big announcement, not soaring but hovering. This should have had this stock soaring, but it did not. This isn’t a good thing, it is a big concern.
Pfizer looks like it has little upside and some significant downside, with a real potential to turn ugly. Vaccine companies during pandemics might seem like a fabulous choice, but are generally too risky at the best of times. You are taking a big chance, and the big chance needs to be worth it. Pfizer is not right now in spite of the celebration.
Chief Editor, MarketReview.com
Ken has a way of making even the most complex of ideas in finance simple enough to understand by all and looks to take every topic to a higher level.
Contact Ken: ken@marketreview.com
Areas of interest: News & updates from the Federal Reserve System, Investing, Commodities, Exchange Traded Funds & more.